Abstract
This is the protocol for a review and there is no abstract. The objectives are as follows: To investigate the clinical and adverse effects of bifeprunox for people with schizophrenia. It is anticipated that it may be possible to undertake several subgroup analyses within this review (see Subgroup analysis and investigation of heterogeneity).
Cite
CITATION STYLE
APA
Chattopadhyay, A., Frey, S., Green, G., Harkness, A., Mcdermott, A., & Yates, A. (2016). Bifeprunox versus placebo for schizophrenia. Cochrane Database of Systematic Reviews, 2016(1). https://doi.org/10.1002/14651858.CD012029
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.
Already have an account? Sign in
Sign up for free